Exelixis
EXEL
#1846
Rank
โ‚น1.021 T
Marketcap
โ‚น3,796
Share price
-2.18%
Change (1 day)
33.38%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company